Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinical and journalistic breakdown of what peptide protocols Andrew Huberman likely uses, whether compounded or branded options fit his public statements, and what the science actually shows.
Read clinical reviewA clinical breakdown of Andrew Huberman's publicly discussed peptide stack, the published evidence behind each compound, and how outcomes for general patients compare to what Huberman reports.
Read clinical reviewA clinical look at how Andrew Huberman's public discussion of peptide stacks, BPC-157, TB-500, and related compounds has driven telehealth demand, and what the evidence actually supports.
Read clinical reviewA journalistic and clinical breakdown of how Andrew Huberman's public discussion of peptide stacks moved from mainstream acceptance to regulatory scrutiny, and what the science actually says.
Read clinical reviewA clinical and journalistic review of Andrew Huberman's peptide discussions, covering FDA regulatory status, FTC influencer disclosure rules, and the published evidence behind BPC-157, TB-500, and related compounds.
Read clinical reviewA clinical and journalistic analysis of Andrew Huberman's reported peptide protocols, with photographic before/after context, mechanism-of-action breakdowns, and primary-source citations on BPC-157, TB-500, and related compounds.
Read clinical reviewA clinical and journalistic breakdown of the peptide protocols Andrew Huberman has discussed publicly, the private-clinic process behind them, and what the peer-reviewed evidence actually says about BPC-157, TB-500, CJC-1295, and more.
Read clinical reviewA clinical breakdown of Andrew Huberman's peptide stack, what compounded peptides actually cost for a celebrity vs. A regular telehealth patient, and what the evidence says about BPC-157, TB-500, and growth hormone secretagogues.
Read clinical review